Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease

被引:27
作者
Cortez-Pinto, Helena [1 ]
Liberal, Rodrigo [2 ,3 ]
Lopes, Susana [2 ,3 ]
Machado, Mariana, V [1 ,4 ]
Carvalho, Joana [1 ]
Dias, Teresa [5 ]
Santos, Arsenio [5 ]
Agostinho, Claudia [6 ]
Figueiredo, Pedro [6 ]
Loureiro, Rafaela [7 ]
Martins, Alexandra [8 ]
Alexandrino, Goncalo [8 ]
Cotrim, Isabel [9 ]
Leal, Carina [9 ]
Presa, Jose [10 ]
Mesquita, Monica [10 ]
Nunes, Joana [11 ]
Gouveia, Catarina [11 ]
Vale, Ana Horta E. [12 ]
Alves, Ana Luisa [13 ]
Coelho, Mariana [13 ]
Maia, Luis [14 ]
Pedroto, Isabel [14 ]
Banhudo, Antonio [15 ]
Pinto, Joao Sebastiao [15 ]
Gomes, Marta Vargas [16 ]
Oliveira, Joana [16 ]
Andreozzi, Valeska [16 ]
Calinas, Filipe [7 ]
机构
[1] Univ Lisbon, Clin Univ Gastrenterol, Ctr Hosp Lisboa Norte, Fac Med,Dept Gastrenterol, Lisbon, Portugal
[2] Ctr Hosp & Univ Sao Joao, Gastroenterol Dept, Porto, Portugal
[3] Univ Porto, Fac Med, Gastroenterol Dept, Porto, Portugal
[4] Hosp Vila Franca de Xira, Gastroenterol Dept, Vila Franca De Xira, Portugal
[5] Ctr Hosp & Univ Coimbra, Dept Internal Med, Coimbra, Portugal
[6] Ctr Hosp & Univ Coimbra, Gastroenterol Dept, Coimbra, Portugal
[7] Cent Lisbon Hosp Ctr, Gastroenterol Dept, Lisbon, Portugal
[8] Hosp Prof Doutor Fernando da Fonseca, Gastroenterol Dept, Lisbon, Portugal
[9] Ctr Hosp Leiria, Gastroenterol Dept, Leiria, Portugal
[10] Ctr Hosp Tras Os Montes & Alto Douro, Internal Med Dept, Liver Unit, Vila Real, Portugal
[11] Hosp Beatriz Angelo, Gastroenterol Dept, Lisbon, Portugal
[12] Hosp Arrabida, Porto, Portugal
[13] Ctr Hosp Setubal, Gastroenterol Dept, Setubal, Portugal
[14] Ctr Hosp Univ Porto, Gastroenterol Dept, Porto, Portugal
[15] Unidade Local Saude Castelo Branco, Gastroenterol Dept, Castelo Branco, Portugal
[16] Exigo Consultores, Lisbon, Portugal
关键词
Barcelona; GLOBE; Paris; PBC; predictors; primary biliary cholangitis; response; score; UDCA; ursodeoxycholic acid; BIOCHEMICAL RESPONSE; CIRRHOSIS; EPIDEMIOLOGY; DIAGNOSIS; PBC;
D O I
10.1002/ueg2.12095
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The current standard of treatment in primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), although a considerable proportion of patients show incomplete response resulting in disease progression. Objective This study aimed to assess the prevalence of incomplete response to UDCA and determine associated patients' characteristics. Methods Patients with PBC as main diagnosis were included from a national multicentric patient registry-Liver.pt. Main endpoints included incomplete response to UDCA treatment according to Barcelona, Paris I and Paris II criteria, Globe and UK PBC scores and the association between baseline characteristics and incomplete response according to Paris II criteria. Results A total of 434 PBC patients were identified, with a mean age of 55 years and 89.2% females. Nearly half of patients were asymptomatic at diagnosis and 93.2% had positive anti-mitochondrial antibodies. Almost all patients (95.6%) had been prescribed at least one drug for PBC treatment. At the last follow-up visit, 93.3% were under treatment of which 99.8% received UDCA. Incomplete response to UDCA was observed in 30.7%, 35.3%, 53.7% and 36.4% of patients according to Barcelona, Paris I, Paris II criteria and Globe score, respectively. After adjusting for age and sex, and accordingly to Paris II criteria, the risk for incomplete biochemical response was 25% higher for patients with cirrhosis at diagnosis (odds ratio [OR] = 1.25; 95% confidence interval [95%CI]: 1.02-1.54; p = 0.033) and 35% (95%CI:1.06-1.72; p = 0.016) and 5% (OR = 1.05; 95%CI:1.01-1.10; p = 0.013) for those with elevated gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP). Conclusion A considerable proportion of patients showed incomplete biochemical response to UDCA treatment according to Paris II criteria. Cirrhosis, elevated GGT and ALP at diagnosis were identified as associated risk factors for incomplete response. Early identification of patients at risk of incomplete response could improve treatment care and guide clinical decision to a more careful patient monitorization.
引用
收藏
页码:699 / 706
页数:8
相关论文
共 31 条
[1]   Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis [J].
Azemoto, Nobuaki ;
Abe, Masanori ;
Murata, Yosuke ;
Hiasa, Yoichi ;
Hamada, Maho ;
Matsuura, Bunzo ;
Onji, Morikazu .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (06) :630-634
[2]   Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER [J].
Bernts, Lucas H. P. ;
Jones, David E. J. ;
Kaatee, Marleen M. ;
Lohse, Ansgar W. ;
Schramm, Christoph ;
Sturm, Ekkehard ;
Drenth, Joost P. H. .
ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
[3]   Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis' [J].
Beuers, Ulrich ;
Gershwin, M. Eric ;
Gish, Robert G. ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lindor, Keith ;
Ma, Xiong ;
Mackay, Ian R. ;
Pares, Albert ;
Tanaka, Atsushi ;
Vierling, John M. ;
Poupon, Raoul .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (05) :E57-E59
[4]   The diagnosis of primary biliary cirrhosis [J].
Bowlus, Christopher L. ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :441-444
[5]   The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis [J].
Carbone, Marco ;
Sharp, Stephen J. ;
Flack, Steve ;
Paximadas, Dimitrios ;
Spiess, Kelly ;
Adgey, Carolyn ;
Griffiths, Laura ;
Lim, Reyna ;
Trembling, Paul ;
Williamson, Kate ;
Wareham, Nick J. ;
Aldersley, Mark ;
Bathgate, Andrew ;
Burroughs, Andrew K. ;
Heneghan, Michael A. ;
Neuberger, James M. ;
Thorburn, Douglas ;
Hirschfield, Gideon M. ;
Cordell, Heather J. ;
Alexander, Graeme J. ;
Jones, David E. J. ;
Sandford, Richard N. ;
Mells, George F. .
HEPATOLOGY, 2016, 63 (03) :930-950
[6]   Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid [J].
Carbone, Marco ;
Mells, George F. ;
Pells, Greta ;
Dawwas, Muhammad F. ;
Newton, Julia L. ;
Heneghan, Michael A. ;
Neuberger, James M. ;
Day, Darren B. ;
Ducker, Samantha J. ;
Sandford, Richard N. ;
Alexander, Graeme J. ;
Jones, David E. J. .
GASTROENTEROLOGY, 2013, 144 (03) :560-+
[7]   Primary biliary cirrhosis [J].
Carey, Elizabeth J. ;
Ali, Ahmad H. ;
Lindor, Keith D. .
LANCET, 2015, 386 (10003) :1565-1575
[8]   Effects of Age and Sex of Response to Ursodeoxycholic Arid and Transplant-free Survival in Patients With Primary Biliary Cholangitis [J].
Cheung, Angela C. ;
Lammers, Willem J. ;
Perez, Carla F. Murillo ;
van Buuren, Henk R. ;
Gulamhusein, Aliya ;
Trivedi, Palak J. ;
Lazaridis, Konstantinos N. ;
Ponsioen, Cyriel Y. ;
Floreani, Annarosa ;
Hirschfield, Gideon M. ;
Corpechot, Christophe ;
Mayo, Marlyn J. ;
Invernizzi, Pietro ;
Battezzati, Pier Maria ;
Pares, Albert ;
Nevens, Frederik ;
Thorburn, Douglas ;
Mason, Andrew L. ;
Carbone, Marco ;
Kowdley, Kris V. ;
Bruns, Tony ;
Dalekos, George N. ;
Gatselis, Nikolaos K. ;
Verhelst, Xavier ;
Lindor, Keith D. ;
Lleo, Ana ;
Poupon, Raoul ;
Janssen, Harry L. A. ;
Hansen, Bettina E. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) :2076-+
[9]   Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis [J].
Corpechot, Christophe ;
Abenavoli, Ludovico ;
Rabahi, Nabila ;
Chretien, Yves ;
Andreani, Tony ;
Johanet, Catherine ;
Chazouilleres, Olivier ;
Poupon, Raoul .
HEPATOLOGY, 2008, 48 (03) :871-877
[10]   Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome [J].
Corpechot, Christophe ;
Chazouilleres, Olivier ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2011, 55 (06) :1361-1367